Form 4: National Health Investors CFO Acquires Shares and Stock Options

John L. Spaid, CFO of National Health Investors, acquired 3,000 shares of common stock and multiple tranches of stock options on February 23, 2024.

Summary

• On February 23, 2024, John L. Spaid, the CFO/EVP Finance of National Health Investors Inc. (NHI), acquired 3,000 shares of common stock at $0 and was granted multiple tranches of stock options.
• The acquired shares are restricted stock that will vest 20% annually, starting February 23, 2025.
• Spaid also acquired stock options to purchase 8,500 shares of common stock at an exercise price of $57.76, vesting in three tranches starting February 23, 2024, February 23, 2025, and February 23, 2026, all expiring on February 23, 2029.
• The filing also details Spaid's existing holdings of stock options granted in previous years, with exercise prices ranging from $53.41 to $90.79 and expiration dates in 2025, 2026, 2027 and 2028.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing showing insider transactions. The acquisition of shares and options could be seen as a positive signal, but it's not definitively bullish.

Positives

• The acquisition of shares and stock options by the CFO could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's view of the company's prospects.

Stakeholder Impact

• The transactions could have a minor positive impact on shareholder sentiment if interpreted as a sign of confidence from the CFO.

Key Dates